Evaluation of pre- and postprandial growth hormone (GH)-releasing hormone-induced GH response in subjects with persistent body weight normalisation after biliopancreatic diversion

International Journal of Obesity

Volumn 22, Issue 10, 1998, Pages 1011-1018

  De Marinis, L ^a,d   Mancini, A ^a   Valle, D ^b   Tacchino, R M ^c   Bianchi, A ^a   Gentilella, R ^a   Perrelli, M ^a   Castagneto, M ^c   Gasbarrini, G ^b  

^a Division of Endocrinology   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c Institutes of Clinical Surgery   (Italy)

^d NONE   (Italy)

Author keywords

Biliopancreatic diversion; Growth hormone; Growth hormone releasing hormone; Obesity; Somatostatin

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; SOMATOSTATIN;

ADULT; ARTICLE; BILIOPANCREATIC BYPASS; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GROWTH HORMONE RELEASE; HUMAN; INTESTINE BYPASS; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 0031686093     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800719     Document Type: Article

References (33)

1. Beck P, Koumans JHT, Winterling CA, Stein MP, Daughaday WH, Kipnis DM. Studies of insulin and growth hormone secretion in human obesity. J Lab Clin Med 1964; 64: 654-667.
2. Jung R. Endocrinological aspects in obesity. In: James WPT (ed). Clinics in Endocrinology and Metabolism, vol. 13. Saunders: Philadelphia, 1984, pp 597-612.
3. Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA. Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. New Engl J Med 1984; 311: 1403-1407.
4. Tanaka K, Inoue S, Numata K, Okazaki H, Nakamura S, Takamura Y. Very-low-caloric diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity. Metabolism 1990; 39: 892-896.
5. Kelijman M, Frohman LA. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary manipulation in obese and nonobese subjects. J Clin Endocrinol Metab 1988; 66: 489-494.
6. De Marinis L, Folli G, D'Amico C, Mancini A, Sambo P, Tofani A, Oradei A, Barbarino A. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-Releasing Hormone in normal subjects and patients with obesity and anorexia nervosa. J Clin Endocrinol Metab 1988; 66: 598-604.
7. Scopinaro N, Gianetta E, Adami GF, Friedman D, Traverso E, Marinari GM, Cuneo S, Vitale B, Ballari F, Baschieri G, Bachi V. Biliopancreatic diversion for obesity at eighteen years. Surgery 1996; 119: 261-268.
8. Tataranni PA, Mingrone G, Greco AV, Caradonna P, Capristo E, Raguso CA, De Gaetano A, Tacchino RM, Castagneto M. Glucose-induced thermogenesis in postobese women who have undergone biliopancreatic diversion. Am J Clin Nutr 1994; 60: 320-326.
9. Castagneto M, De Gaetano A, Mingrone G, Tacchino RM, Capristo E, Benedetti G, Tataranni PA, Greco AV. Normalization of insulin sensitivity in the obese subjects after stable weight reduction with biliopancreatic diversion. Obes Surg 1994; 4: 161-168.
10. Sarson DL, Scopinaro N, Bloom SR. Gut hormone changes after jejunoileal (JIB) or biliopancreatic bypass surgery for morbid obesity. Int J Obes 1981; 5: 471-480.
11. Gasbarrini G, Mingrone G, Greco AV, Castagneto M. An 18 year old woman with familial chylomicronoemia who would not stick to a diet. Lancet 1996; 30: 1524-1525.
12. Chen D, Nylander AG, Rehfeld JF, Sundler F, Hakanson R. Hypercholecystokininemia produced by pancreaticobiliary diversion causes gastrin-like effects on enterochromaffin-like cells in the stomach of rats subjected to portacaval shunting or antrectomy. Scand J Gastroenterol 1993; 28: 988-992.
13. De Marinis L, Mancini A, Zuppi P, D'Amico C, Fiumara C, Calabrò F, Lagonigro G, La Brocca A. GH response to GHRH before and after meals at different hours of the day in obese patients. Psychoneuroendocrinology 1991; 16: 361-365.
14. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich J. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 1990; 70: 1292-1298.
15. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. The ratio between serum insulin-like growth factor (IGF)-1 and the IGF binding proteins (IGFBP-1,-2,-3) decreases with age and is increased in acromegalic patients. Clin Endocrinol (Oxf) 1994; 41: 85-93.
16. De Marinis L, Mancini A, Folli G, D'Amico C, Corsello SM, Sciuto R, Tofani A, Sambo P, Barbarino A. Naloxone inhibition of post-prandial growth hormone releasing hormone-induced growth hormone release in obesity. Neuroendocrinology 1989; 50: 529-532.
17. Bercu BB, Yang SW, Masuda R, Hu CS, Waker RF. Effects of coadministered growth hormone (GH)-releasing hormone and GH-releasing hexapeptide on maladaptive aspects of obesity in Zucker rats. Endocrinology 1992; 131: 2800-2804.
18. Imaki T, Shibasaki T, Shizume K, Masuda A, Hotta M, Kiyosawa Y, Jibiki K, Demura H, Taushima T, Ling K. The effects of free fatty acids on Growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 1985; 60: 290-293.
19. Imaki T, Shibasaki T, Masuda A, Hotta M, Yamauchi N, Demura H, Shizmuze K, Wakabayashi I, Ling N. The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats. Endocrinology 1986; 118: 2390-2394.
20. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 1995; 80: 1407-1415.
21. Melmed S. Insulin suppresses growth hormone by rat pituitary cells. J Clin Invest 1984; 73: 1425-1433.
22. Cordido F, Casanueva FF, Dieguez C. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release in obesity. J Clin Endocrinol Metab 1989; 68: 290-293.
23. Maccario M, Procopio M, Grottoli S, Oleandri SE, Razzore P, Camanni F, Ghigo E. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose. J Clin Endocrinol Metab 1995; 80: 3774-3778.
24. Lloyd KC. Gut hormones in gastric function. Baillieres Clin Endocrinol Metab 1994; 8: 111-136.
25. Pirke KM, Friess E, Kellner MB, Krieg JC, Fichter MM. Somatostatin in eating disorders. Int J Eat Disord 1994; 15: 99-102.
26. Rasmussen MH, Frystyk J, Andersen T, Breum L, Christiansen JS, Hilsted J. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin and growth hormone. Metabolism 1994; 43: 315-319.
27. De Marinis L, Mancini A, Zuppi P, Fiumara C, Fabrizi ML, Sammartano L, Conte G, Valle D, Daini S, Ferro FM. Opioid dysregulation in anorexia nervosa: naloxone effects on preprandial and postprandial growth hormone response to growth hormone-releasing hormone. Metabolism 1994; 43: 140-143.
28. Thomas GB, Cummins JT, Francis H, Sudbury AW, McCloud PI, Clarke IJ. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomised ewes. Endocrinology 1991; 128: 1151-1158.
29. Janowski BA, Ling NC, Giustina A, Wehrenberg WB. Hypothalamic regulation of growth hormone secretion during food deprivation in the rat. Life Sci 1993; 52: 981-987.
30. Mancini A, Valle D, Conte G, Fiumara C, Perrelli M, Fabrizi ML. Bianchi A, De Marinis L. Pre- and postprandial pyridostigmine and oxiracetam effects on growth hormone secretion in anorexia nervosa. Psychoneuroendocrinology 1996; 21: 621-629.
31. Rolla M, Andreoni A, Bellitti D, Federghini M, Ferranini E. Failure of glucose infusion to suppress the exaggerated GH responses to GHRH in patients with anorexia nervosa. Biol Psychiatry 1990; 27: 215-222.
32. Rolla M, Andreoni A, Bellitti D, Cristofani R, Federghini M, Muller EE. Blockade of cholinergic muscarinic receptor by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorders. Biol Psychiatry 1991; 29: 1079-1091.
33. Tamai H, Takemura J, Kobayashi N, Matsubayashi S, Matsukura S, Nakagawa T. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism 1993; 42: 581-584.